KUVAN (SAPROPTERIN DIHYDROCHLORIDE) — FDA Approval NDA205065 (BIOMARIN PHARM)
KUVAN (SAPROPTERIN DIHYDROCHLORIDE) — FDA Approval NDA205065 (BIOMARIN PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: KUVAN; Active ingredients: SAPROPTERIN DIHYDROCHLORIDE; Application number: NDA205065.
| Brand name | KUVAN |
|---|---|
| Active ingredients | SAPROPTERIN DIHYDROCHLORIDE |
| Application number | NDA205065 |
| Sponsor | BIOMARIN PHARM |
| Dosage form | POWDER |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20131219 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →